FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

21208411000001101: Linagliptin 2.5mg / Metformin 1g tablets 56 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Oct 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
70890801000001114 Linagliptin 2.5mg / Metformin 1g tablets 56 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
70890901000001115 Linagliptin 2.5mg / Metformin 1g tablets 56 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Linagliptin 2.5mg / Metformin 1g tablets 56 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets 56 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets 56 tablet Has VMP Linagliptin 2.5mg / Metformin 1g tablets true Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets 56 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets 56 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets 56 tablet Has specific active ingredient Metformin hydrochloride true Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets 56 tablet Has specific active ingredient Linagliptin false Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets 56 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets 56 tablet Has specific active ingredient Linagliptin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Jentadueto 2.5mg/1000mg tablets (Mawdsley-Brooks & Company Ltd) 56 tablet Is a True Linagliptin 2.5mg / Metformin 1g tablets 56 tablet Inferred relationship Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets Is a True Linagliptin 2.5mg / Metformin 1g tablets 56 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start